Projecting Big Growth For This $13 Billion Biotech Name
Here is how to initiate a holding in the name with a covered call order.
Psst: These Two Biotech Plays Look Like Great Under-the-Radar Deals
Let’s check out two biopharma plays that scream ‘growth at a reasonable price.’
Rising Rates, Record Diesel Prices Make a Toxic Brew
There are two major risks that investors seem more than happy to underweigh.
Way Up at the Top of This Wobbly Market Is One, Huge AI Trade
Let’s look at the concentration risks investors shouldn’t be ignoring.
How to Trade This Cash-Rich Biopharma Name
This weekend’s covered call idea is around a cash-rich biopharma concern that is expecting a key FDA approval to close out 2026.
Citigroup Turns to 2 Promising Biotech Stocks
Citigroup initiated coverage on a pair of names with new buy ratings.
Here’s Where I’m Keeping My Dry Powder Safe From Market Headwinds
AI valuation absurdity continues, rates are spiking and housing prices are getting weird.
The AI End Game Appears to Be Growing Near
Unfortunately, it is hard to see the AI infrastructure buildout maintaining this pace.
How to Join Michael Burry’s Birkenstock Bet
Here’s a covered-call strategy to join the “Big Short” investor’s fashion bet.
Three Biotechs Bolstered by Positive News
Biotech has been a market laggard lately, but I’m eyeing three companies making recent progress.